Galantamine introduced in Europe.
D000110:Acetylcholinesterase / Q000187:drug effects; D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003071:Cognition / Q000187:drug effects*; D017277:Drug Approval; D005060:Europe; D005702:Galantamine / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D018697:Nootropic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D011978:Receptors, Nicotinic / Q000187:drug effects
D018697:Nootropic Agents; D011978:Receptors, Nicotinic; D005702:Galantamine; D000110:Acetylcholinesterase